This inventor holds 2 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: The Innovations of Shozo Sakuma
Introduction
Shozo Sakuma is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of medical research, particularly in the areas of allergic disorders and eye diseases. With a total of 2 patents, his work has had a meaningful impact on healthcare.
Latest Patents
Sakuma's latest patents include an innovative animal model for allergic disorders. This model involves an immuno-modulated animal that has been sensitized with an antigen in a specific pathogen-free environment. The animal displays allergy symptoms caused by the antigen, providing valuable insights for research. Another significant patent involves the use of macrolide compounds for treating glaucoma. These compounds, including FK506 and its related substances, are aimed at preventing or treating eye diseases, particularly glaucoma. The composition containing these compounds is also disclosed in his patent.
Career Highlights
Throughout his career, Shozo Sakuma has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Sakuma has collaborated with notable colleagues, including Yasuyuki Higashi and Tatsuya Sasakawa. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
Shozo Sakuma's contributions to medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of allergic disorders and glaucoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

